Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors

Journal of Neurochemistry

Volumn 99, Issue 4, 2006, Pages 1311-1319

  Navailles, Sylvia ^a   Moison, Delphine ^a   Ryczko, Dimitri ^a   Spampinato, Umberto ^a  

^a CNRS   (France)

Author keywords

Constitutive activity; Dopamine release; Nucleus accumbens; Rat; Serotonin2C receptors; Ventral tegmental area

Indexed keywords

1,2,3,5 TETRAHYDRO 5 METHYL 1 (3 PYRIDYLCARBAMOYL)PYRROLO[2,3 F]INDOLE; 2 (6 CHLORO 5 FLUORO 1 INDOLYL) 1 METHYLETHYLAMINE; 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL] 6 TRIFLUOROMETHYLINDOLINE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; HALOTHANE; SEROTONIN 2C AGONIST; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; TEGMENTUM;

ANIMALS; DOPAMINE; EXTRACELLULAR FLUID; MALE; MICRODIALYSIS; NEURAL INHIBITION; NEURAL PATHWAYS; NEURONS; NUCLEUS ACCUMBENS; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SYNAPTIC TRANSMISSION; VENTRAL TEGMENTAL AREA;

EID: 33750451628     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04188.x     Document Type: Article

References (45)

1. Bayer V. E. and Pickel V. M. (1991) GABA-labeled terminals form proportionally more synapses with dopaminergic neurons containing low densities o tyrosine hydroxylase-immunoreactivity in rat ventral tegmental area. Brain Res. 559, 44-55.
2. Berg K. A., Harvey J. A., Spampinato U. and Clarke W. P. (2005) Physiological relevance of constitutive activity of 5-HT2A and 5-HT2C receptors. Trends Pharmacol. Sci. 26, 625-630.
3. Berg K. A., Navailles S., Sanchez T. A., Silva Y. M., Wood M. D., Spaminato U. and Clarke W. P. (2006) Differential effects of SB243213 on 5-HT2E Receptor-Mediated Responses. J. Pharmacol. Exp. Ther. DOI: 10.1124/jpet.106. 104448.
4. Burns C. M., Chu H., Reuter S. M., Hutchinson L. K., Canton H., Sanders-Bush E. and Emeson R. B. (1997) Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387, 303-308.
5. Burstein E. S., Spalding T. A., Brauner-Osborne H. and Brann M. R. (1995) Constitutive activation of muscarinic receptors by the G-protein Gq. FEBS Lett. 363, 261-263.
6. Clemett D. A., Punhani T., Duxon M. S., Blackburn T. P. and Fone K. C. (2000) Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS. Neuropharmacology 39, 123-132.
7. De Deurwaerdère P., Navailles S., Berg K. A., Clarke W. P. and Spampinato U. (2004) Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens. J. Neurosci. 24, 3235-3241.
8. De Deurwaerdère P., Stinus L. and Spampinato U. (1998) Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: role of 5-HT3 receptors. J. Neurosci. 18, 6528-6538.
9. Di Giovanni G., De Deurwaerdère P., Di Mascio M., Di Matteo V., Esposito E. and Spampinato U. (1999) Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study. Neuroscience 91, 587-597.
10. 2C receptors. Neuroscience 103, 111-116.
11. Di Matteo V., Cacchio M., Di Giulio C. and Esposito E. (2002) Role of serotonin (2C) receptors in the control of brain dopaminergic function. Pharmacol. Biochem. Behav. 71, 727-734.
12. Di Matteo V., Di Giovanni G., Di Mascio M. and Esposito E. (1999) SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology 38, 1195-1205.
13. Di Matteo V., Di Giovanni G., Di Mascio M. and Esposito E. (2000) Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin (2C) receptors. Brain Res. 865, 85-90.
14. Dunnett S. B. and Robbins T. W. (1992) The functional role of mesotelencephalic dopamine systems. Biol. Rev. Camb. Philos. Soc. 67, 491-518.
15. Eberle-Wang K., Mikeladze Z., Uryu K. and Chesselet M. F. (1997) Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats. J. Comp. Neurol. 384, 233-247.
16. Fallon J. H. and Moore R. Y. (1978) Catecholamine innervation of basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J. Comp. Neurol. 180, 545-580.
17. Filip M. and Cunningham K. A. (2002) Serotonin 5-HT2C receptors in nucleus accumbens regulate expression of the hyperlocomotive and discriminative stimulus effects of cocaine. Pharmacol. Biochem. Behav. 71, 745-756.
18. Filip M. and Cunningham K. A. (2003) Hyperlocomotive and discriminative stimulus effects of cocaine are under the control of serotonin2C (5-HT2C) receptors in rat prefrontal cortex. J. Pharmacol. Exp. Ther. 306, 734-743.
19. Fletcher P. J., Chintoh A. F., Sinyard J. and Higgins G. A. (2004) Injection of the 5-HT2C receptor agonist Ro60-0175 into the ventral tegmental area reduces cocaine-induced locomotor activity and cocaine self-administration. Neuropsychopharmacology 29, 308-318.
20. Gobert A., Rivet J. M., Lejeune F., Newman-Tancredi A., Adhumeau-Auclair A., Nicolas J. P., Cistarelli L., Melon C. and Millan M. J. (2000) Serotonin (2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse 36, 205-221.
21. Herrick-Davies K., Grinde E. and Teitler M. (2000) Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors. J. Pharmacol. Exp. Ther. 295, 226-232.
22. 2C receptors. Eur. J. Pharmacol. 480, 151-162.
23. Ikemoto S., Kohl R. R. and McBride W. J. (1997) GABA (A) receptor blockade in the anterior ventral tegmental area increases extracellular levels of dopamine in the nucleus accumbens of rats. J. Neurochem. 69, 137-143.
24. Kalivas P. W., Churchill L. and Klitenick M. A. (1993) GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area. Neuroscience 57, 1047-1060.
25. Kennett G. A., Wood M. D., Bright F. et al. (1996) In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties. Br. J. Pharmacol. 117, 427-434.
26. Kennett G. A., Wood M. D., Bright F. et al. (1997) SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology 36, 609-620.
27. Koob G. F. (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13, 177-184.
28. Lucas G. and Spampinato U. (2000) Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum. J. Neurochem. 74, 693-701.
29. Marion S., Weiner D. M. and Caron M. G. (2004) RNA editing induces variation in desensitization and trafficking of 5-hydroxytryptamine2c receptor isoforms. J. Biol. Chem. 279, 2945-2954.
30. 2C receptor agonists: Pharmacological characteristics and therapeutic potential. J. Pharmacol. Exp. Ther. 286, 913-924.
31. McMahon L. R., Filip M. and Cunningham K. A. (2001) Differential regulation of the mesoaccumbens circuit by serotonin 5-hydroxytryptamine 5-HT2A and 5-HT2C receptors. J. Neurosci. 21, 7781-7787.
32. Milligan G., Bond R. A. and Lee M. (1995) Inverse agonism: Pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol. Sci. 16, 10-13.
33. Navailles S., De Deurwaerdère P., Porras G. and Spampinato U. (2004) In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum. Neuropsychopharmacology 29, 319-326.
34. Navailles S., De Deurwaerdère P. and Spampinato U. (2006) Clozapine and haloperidol differentially alter the constitutive activity of central serotonin2C receptors in vivo. Biol. Psychiatry 59, 568-575.
35. Niswender C. M., Copeland S. C., Herrick-Davis K., Emeson R. B. and Sanders-Bush E. (1999) RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J. Biol. Chem. 274, 9472-9478.
36. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. New York: Academic press.
37. Pompeiano M., Palacios J. M. and Mengod G. (1994) distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res. Mol. Brain Res. 23, 163-178.
38. Porras G., Di Matteo V., Fracasso C., Lucas G., De Deurwaerdère P., Caccia S., Esposito E. and Spampinato U. (2002) 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropsychopharmacology 26, 311-324.
39. Pozzi L., Acconcia S., Ceglia I., Invernizzi R. W. and Samanin R. (2002) Stimulation of 5-hydroxytryptamine (5-HT (2C) receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex. J. Neurochem. 82, 93-100.
40. Rauser L., Savage J. E., Meltzer H. Y. and Roth B. L. (2001) Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine (2C) receptor. J. Pharmacol. Exp. Ther. 299, 83-89.
41. Svenningsson P., Tzavara E. T., Liu F., Fienberg A. A., Nomikos G. G. and Greengard P. (2002) DARPP-32 mediates serotoninergic neurotransmission in the forebrain. Proc. Natl. Acad. Sci. USA 99, 3188-3193.
42. Tecott L. H., Sun L. M., Akana S. F., Strack A. M., Lowenstein D. H., Dallman M. F. and Julius D. (1995) Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 374, 542-546.
43. Wood M. D., Reavill C., Trail B. et al. (2001) SB-243213, a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety. Neuropharmacology 41, 186-199.
44. Yan Q. S. (2000) Activation of 5-HT2A/2C receptors within the nucleus accumbens increases local dopaminergic transmission. Brain Res. Bull. 51, 75-81.
45. Zachariou V., Benoit-Marand M., Allen P. B., Ingrassia P., Fienberg A. A., Gonon F., Greengard P. and Picciotto M. R. (2002) Reduction of cocaine place preference in mice lacking the protein phosphatase 1 inhibitors DARPP-32 or Inhibitor 1. Biol. Psychiatry 51, 612-620.